Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Global Urinary Tract Infection Testing Market Snapshot (2023 to 2033)

The global urinary tract infection testing market was valued at US$ 563.0 Million in 2022 and is expected to reach US$ 1.1 Billion by 2033. The urinalysis test with around 48.5% in terms of value share, has topped the global market within the testing category in 2022 and is expected to grow at a CAGR of close to 6.0% over the forecast period (2023 to 2033)

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 563.0 Million
Market Value 2023 US$ 593.7 Million
Market Value 2033 US$ 1.1 Billion
CAGR 2023 to 2033 6.0%
Market Share of Top 5 Countries 53.5%
Key Market Players ACON Laboratories Inc., Cardinal Health Inc., Danaher Corporation, SYSMEX CORPORATION, Abbott Laboratories, Bio-Rad Laboratories, Roche AG, LabCorp(Laboratory Corporation of America Holdings)., Stryker Corporation, Thermo Fisher Scientific, Inc.

Globally, the number of people suffering from urinary tract infections has increased. Urinary tract infection adds to the world's second-largest patient pool. The market is expected to rise because of rising UTI prevalence and desire for better treatment options. The introduction of innovative testing kits and equipment is likely to propel the urine infection testing industry forward.

  • For example, in June 2019, MiDOG, LLC announced the release of a new collection of urine kits and tests for the detection of fungal and bacterial pathogens in canine urinary tract illnesses.

With the introduction of new technologies and an increase in the number of urinary tract infection testing kits and device players, the urinary tract infection testing market is likely to expand over the upcoming years.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Urinary Tract Infection Testing Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

The global market for urinary tract infection testing was around 1.6% of the US$ 35.0 Billion of the global infectious disease diagnostics market in 2022.

One of the most prevalent bacterial infections, impacting almost 150 million individuals worldwide, is urinary tract infection. Urinary tract infection is most commonly caused by bacteria, viruses, and fungus in the urinary tract. Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, Proteus species, and Enterococcus species are few bacteria that cause urinary tract infections.

  • According to the European Association of Urology, bacterial resistance to antibiotics is increasing in the region, necessitating greater research and development for innovative therapies. The urinary tract infection testing market will rise due to the latest emerging approaches.

There is a growing interest in developing creative and effective technology that can quickly and reliably identify UTIs and select the optimum antibiotic to use for a specific patient. This, along with the other factors mentioned, are projected to drive the market in the coming year.

Owed to the above factors, the global market is projected to grow at CAGR of 6.0% in forecasted period.

What are the Key Opportunities for the Urinary Tract Infection Testing Service Providers?

Recurrence of urinary tract infections is very common, even in uncomplicated cases.

  • The incidence of recurrent UTI cases accounts for 90% of the cases as per the research article published in National Institute of Health Journal, 2022.

Bacterial persistence occurs when treatment is hampered by the buildup of germs in an area that antibiotics cannot reach, such as infected stones, urethral diverticula, and infected paraurethral glands.

Urinary tract infections are also rather common in males. Prostatitis, pyelonephritis, urethritis, cystitis, epididymitis, orchitis, and infected urinary catheters are all included in the group of adult male UTIs. Due to the numerous defenses the male urinary system has, any such infections are typically linked to anatomical anomalies that frequently call for surgical repair.

The increasing incidence of chronic kidney disease, such as renal failure and bladder cancer, is driving the use of catheters and other drainage devices in patients. Patients with urinary catheters are more likely to contract a complicated UTI. This is expected to boost growth in the UTI testing market over the forecast period.

Bacteria enter the urinary system through improper catheter insertion technique or inadequate cleanliness, resulting in infection. Poor hygiene habits, such as neglecting to clean the catheter or drainage bag, might encourage bacterial development and raise the possibility of UTIs. Sometimes, catheters can cause urine to build up or stagnate in the bladder, which can foster the growth of germs. Additionally, blockages in the catheter can prevent urine from flowing normally, causing urinary stasis and a higher risk of infection. All of these factors result in a high demand for testing for UTI.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining the Demand for Urinary Tract Infection Testing?

The accuracy of UTI diagnostic tests varies, which might result in false-positive or false-negative results. This can lead to incorrect diagnosis and treatment recommendations. The limitations of existing diagnostic tests may impede their acceptance and limit the growth of the UTI testing market. The inappropriate and overuse of antibiotics in UTI care can have an impact on the need for UTI testing. Overuse of empirical antibiotic treatment without sufficient diagnostic confirmation can lessen the perceived necessity for diagnostic testing, resulting in UTI test underutilization. Efforts to promote ethical antibiotic usage and evidence-based diagnosis may influence UTI testing demand.

Urine samples are frequently required for UTI diagnostic tests. Obtaining clean-catch urine samples can be difficult, particularly in specific patient populations such as children, the elderly, or those with mobility challenges. Difficulties in collecting samples may have an impact on the accuracy and reliability of UTI tests, limiting their usage.

Country-wise Insights

Why is USA a Prominent Market for Urinary Tract Infection Testing?

The USA occupies 31.7% of market share in 2022 globally. UTI is one of the most common bacterial-caused infectious illnesses in the country. A complex urinary tract infection, which is caused by anatomical or functional abnormalities in the urinary system, can afflict anyone, regardless of gender or age.

  • According to an American Urological Association Education and Research, Inc. 2019, between 50% and 60% of women in the US will have at least one UTI in their lifetime, with approximately 10% of postmenopausal women having a UTI in the previous year.

To avoid complications and achieve optimal patient outcomes, there is a growing emphasis on precise diagnosis and effective therapy of UTIs. As healthcare professionals and patients become more aware of the necessity of diagnostic testing, the demand for UTI tests is increasing.

What Makes China a Highly Lucrative Market for Urinary Tract Infection Testing?

China expenditure on urinary tract infection testing in 2022 was US$ 32.5 Million.

Several policies and programmes have been developed by the Chinese government to enhance healthcare outcomes and minimise healthcare-associated infections, including UTIs.

One key undertaking is the promotion of infection prevention knowledge and education. The goal is to raise awareness among healthcare practitioners and patients about the danger of UTIs and the need of infection prevention.

The government provides healthcare providers with training and instruction to help them improve their knowledge and skills in preventing UTIs. They also concentrate on this effort. Furthermore, encouraging the use of infection prevention measures in healthcare facilities. As a result, China is in high demand in the testing market for urinary tract infections.

What Makes the Germany a Large Market for Urinary Tract Infection Testing?

In 2022, the Germany held a significant share in the European market and contributed around 23.1% value share in 2022. Germany has a well-developed healthcare system that places a high emphasis on diagnostic services and preventive treatment. The availability of improved healthcare infrastructure, such as diagnostic laboratories and clinics, helps to drive the UTI testing market forward. The rising prevalence of UTIs in the country contributes to the development of the UTI testing market.

UTIs are a widespread health problem in Germany, affecting a large number of people each year. UTIs are becoming more common due to factors such as an ageing population, lifestyle changes, and healthcare-associated illnesses. In Germany, this fuels the demand for UTI testing.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Test Is Predicted to Expand Rapidly Between 2023 and 2033?

By test, urinalysis held 48.5% market share in world in 2022.

Urinalysis tests are widely used. They are a simple and non-invasive approach for healthcare experts to assess numerous different elements of human health. Urinalysis is frequently used by healthcare providers to screen for or monitor several common health disorders, such as liver disease, kidney disease, and diabetes. These tests' broad applicability are the reason for their significant market share.

Why Laboratory Test Kits are Preferred Prominently in Urinary Tract Infection Testing?

The market value of laboratory test kits is representing a sizable 73.3% market share in 2022.

Most laboratories use leukocyte esterase rapid tests to replace microscopic leukocyte counts in urine. A more advanced and exact laboratory investigation of the urine validates the results of these test kits. Because of their precision, these test kits are gaining popularity and assisting in market expansion.

Which Indication Is Accelerating the Market Growth?

The Cystitis have a considerable presence in the market with market share of 58.6% in 2022. Due to the ageing population, cystitis is the most prevalent type of UTI. Cystitis is frequent in the elderly, especially when they are ill. Bladder catheters and some urinary-tract procedures may further raise the risk of cystitis.

Which End User is Benefiting the Global Market?

The hospitals have a considerable presence in the urinary tract infection testing market, accounting for 41.7% value share in 2022, and exhibiting a high CAGR of 6.5% over the forecast period. The increased use of laboratory kits in hospitals for UTI detection is resulting in more potent for the UTI treatment, as well as increased patient visits in the hospitals globally each year are aiding the growth of the market.

Competitive Landscape

Collaborations and partnerships among healthcare providers, research institutions, and technology businesses can encourage innovation and hasten urinary tract infection testing. Collaboration in research, development, and commercialization can lead to market expansion and the creation of new applications. Numerous large firms compete in the field of urinary tract infection testing. Among the well-known players in this field are:

  • May 2023, PathogenDx is prepared to introduce a microarray-based test for urinary tract infections later this year after getting its start in the cannabis, food, and COVID-19 testing markets.
  • Feb 2023, Sysmex Launches Automated Urinalysis Testing Solutions at Medlab Middle East, Revolutionising Workflow.

Similarly, recent developments related to the companies active in the urinary tract infection testing market have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Urinary Tract Infection Testing Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value, Units for Volume
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa.
Key Market Segments Covered Test, Test Kits, Indication, End User, and Region
Key Companies Profiled
  • ACON Laboratories Inc.
  • Cardinal Health Inc.
  • Danaher Corporation
  • SYSMEX CORPORATION
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Roche AG
  • LabCorp (Laboratory Corporation of America Holdings).
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc.
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in the Urinary Tract Infection Testing Industry Research

By Tests:

  • Urinalysis
  • Urine Cultures
  • Susceptibility Testing

By Test Kits:

  • Home Test Kits
  • Laboratory Test Kits

By Indication:

  • Cystitis
  • Urethritis
  • Pyelonephritis

By End User:

  • Hospitals
  • Nephropathy Clinics
  • Diagnostic Laboratories
  • others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

What Big was the Global Urinary Tract Infection Testing Market last Year?

The overall market was valued at around US$ 563 million in 2022 end.

What will be the Growth rate in Adoption of Urinary Tract Infection Testing Services?

The adoption of urinary tract infection testing services could grow at 6% annually until 2033.

What is the Projected Global Market Value by 2033?

The global market value to cross US$ 1,100 million by 2033.

Where is the Highest Demand for Urinary Tract Infection Testing Services?

The United States alone had generated nearly 31.7% of the global demand in 2022.

Which is the Best Performing Country for Asia Pacific Market

China market accrued nearly US$ 32.5 million in 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Key Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption/Usage Analysis

    4.2. Key Regulations

    4.3. Value Chain Analysis

    4.4. PESTEL Analysis

    4.5. Key Deals and Mergers

    4.6. List of Service Providers, By Key Countries

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Infectious Disease Diagnostics Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Growing Elderly Population

        5.2.2. Rise in Chronic and Infectious Disease Prevalence

        5.2.3. Rising Research and Development

        5.2.4. Enhancing Healthcare Infrastructure

        5.2.5. Government Regulations in Product Approval

        5.2.6. Increasing Incidences of Catheter Associated UTI

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2017 to 2022

    6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Tests

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Tests

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Tests, 2017 - 2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Tests, 2023 - 2033

        9.3.1. Urinalysis

        9.3.2. Urine Cultures

        9.3.3. Susceptibility Testing

    9.4. Market Attractiveness Analysis By Tests

10. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Test Kits

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Test Kits , 2017 - 2022

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Test Kits, 2023 - 2033

        10.3.1. Home Test Kits

        10.3.2. Laboratory Test Kits

    10.4. Market Attractiveness Analysis By Test Kits

11. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Indication, 2017 - 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 - 2033

        11.3.1. Cystitis

        11.3.2. Urethritis

        11.3.3. Pyelonephritis

    11.4. Market Attractiveness Analysis By Indication

12. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 - 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 - 2033

        12.3.1. Hospitals

        12.3.2. Nephropathy Clinics

        12.3.3. Diagnostic Laboratories

        12.3.4. others

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Region

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. USA

            14.3.1.2. Canada

        14.3.2. By Tests

        14.3.3. By Test Kits

        14.3.4. By Indication

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Tests

        14.4.3. By Test Kits

        14.4.4. By Indication

        14.4.5. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. USA Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Tests

                14.8.1.2.2. By Test Kits

                14.8.1.2.3. By Indication

                14.8.1.2.4. By End User

        14.8.2. Canada Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Tests

                14.8.2.2.2. By Test Kits

                14.8.2.2.3. By Indication

                14.8.2.2.4. By End User

15. Latin America Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Mexico

            15.3.1.2. Brazil

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

                15.3.1.4.1. By Country

                15.3.1.4.2. By Tests

                15.3.1.4.3. By Test Kits

                15.3.1.4.4. By Indication

                15.3.1.4.5. By End User

    15.4. Market Attractiveness Analysis

                15.4.1.1.1. By Country

                15.4.1.1.2. By Tests

                15.4.1.1.3. By Test Kits

                15.4.1.1.4. By Indication

                15.4.1.1.5. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Mexico Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Tests

                15.8.1.2.2. By Test Kits

                15.8.1.2.3. By Indication

                15.8.1.2.4. By End User

        15.8.2. Brazil Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Tests

                15.8.2.2.2. By Test Kits

                15.8.2.2.3. By Indication

                15.8.2.2.4. By End User

        15.8.3. Argentina Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Tests

                15.8.3.2.2. By Test Kits

                15.8.3.2.3. By Indication

                15.8.3.2.4. By End User

16. Europe Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. UK

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Tests

        16.3.3. By Test Kits

        16.3.4. By Indication

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Tests

        16.4.3. By Test Kits

        16.4.4. By Indication

        16.4.5. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Germany Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Tests

                16.8.1.2.2. By Test Kits

                16.8.1.2.3. By Indication

                16.8.1.2.4. By End User

        16.8.2. Italy Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Tests

                16.8.2.2.2. By Test Kits

                16.8.2.2.3. By Indication

                16.8.2.2.4. By End User

        16.8.3. France Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Tests

                16.8.3.2.2. By Test Kits

                16.8.3.2.3. By Indication

                16.8.3.2.4. By End User

        16.8.4. UK Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast By Market Taxonomy

                16.8.4.2.1. By Tests

                16.8.4.2.2. By Test Kits

                16.8.4.2.3. By Indication

                16.8.4.2.4. By End User

        16.8.5. Spain Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast By Market Taxonomy

                16.8.5.2.1. By Tests

                16.8.5.2.2. By Test Kits

                16.8.5.2.3. By Indication

                16.8.5.2.4. By End User

        16.8.6. BENELUX Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast By Market Taxonomy

                16.8.6.2.1. By Tests

                16.8.6.2.2. By Test Kits

                16.8.6.2.3. By Indication

                16.8.6.2.4. By End User

        16.8.7. Russia Market Analysis

            16.8.7.1. Introduction

            16.8.7.2. Market Analysis and Forecast By Market Taxonomy

                16.8.7.2.1. By Tests

                16.8.7.2.2. By Test Kits

                16.8.7.2.3. By Indication

                16.8.7.2.4. By End User

17. East Asia Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Tests

        17.3.3. By Test Kits

        17.3.4. By Indication

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Tests

        17.4.3. By Test Kits

        17.4.4. By Indication

        17.4.5. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. China Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast By Market Taxonomy

                17.8.1.2.1. By Tests

                17.8.1.2.2. By Test Kits

                17.8.1.2.3. By Indication

                17.8.1.2.4. By End User

        17.8.2. Japan Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast By Market Taxonomy

                17.8.2.2.1. By Tests

                17.8.2.2.2. By Test Kits

                17.8.2.2.3. By Indication

                17.8.2.2.4. By End User

        17.8.3. South Korea Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast By Market Taxonomy

                17.8.3.2.1. By Tests

                17.8.3.2.2. By Test Kits

                17.8.3.2.3. By Indication

                17.8.3.2.4. By End User

18. South Asia Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Indonesia

            18.3.1.3. Malaysia

            18.3.1.4. Thailand

            18.3.1.5. Rest of South Asia

        18.3.2. By Tests

        18.3.3. By Test Kits

        18.3.4. By Indication

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Tests

        18.4.3. By Test Kits

        18.4.4. By Indication

        18.4.5. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. India Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast By Market Taxonomy

                18.8.1.2.1. By Tests

                18.8.1.2.2. By Test Kits

                18.8.1.2.3. By Indication

                18.8.1.2.4. By End User

        18.8.2. Indonesia Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast By Market Taxonomy

                18.8.2.2.1. By Tests

                18.8.2.2.2. By Test Kits

                18.8.2.2.3. By Indication

                18.8.2.2.4. By End User

        18.8.3. Malaysia Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast By Market Taxonomy

                18.8.3.2.1. By Tests

                18.8.3.2.2. By Test Kits

                18.8.3.2.3. By Indication

                18.8.3.2.4. By End User

        18.8.4. Thailand Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast By Market Taxonomy

                18.8.4.2.1. By Tests

                18.8.4.2.2. By Test Kits

                18.8.4.2.3. By Indication

                18.8.4.2.4. By End User

19. Oceania Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Tests

        19.3.3. By Test Kits

        19.3.4. By Indication

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Tests

        19.4.3. By Test Kits

        19.4.4. By Indication

        19.4.5. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. Australia Market Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast By Market Taxonomy

                19.7.1.2.1. By Tests

                19.7.1.2.2. By Test Kits

                19.7.1.2.3. By Indication

                19.7.1.2.4. By End User

        19.7.2. New Zealand Market Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast By Market Taxonomy

                19.7.2.2.1. By Tests

                19.7.2.2.2. By Test Kits

                19.7.2.2.3. By Indication

                19.7.2.2.4. By End User

20. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Türkiye

            20.3.1.3. South Africa

            20.3.1.4. Northern Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Tests

        20.3.3. By Test Kits

        20.3.4. By Indication

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Tests

        20.4.3. By Test Kits

        20.4.4. By Indication

        20.4.5. By End User

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. GCC Countries Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast By Market Taxonomy

                20.8.1.2.1. By Tests

                20.8.1.2.2. By Test Kits

                20.8.1.2.3. By Indication

                20.8.1.2.4. By End User

        20.8.2. Türkiye Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast By Market Taxonomy

                20.8.2.2.1. By Tests

                20.8.2.2.2. By Test Kits

                20.8.2.2.3. By Indication

                20.8.2.2.4. By End User

        20.8.3. South Africa Market Analysis

            20.8.3.1. Introduction

            20.8.3.2. Market Analysis and Forecast By Market Taxonomy

                20.8.3.2.1. By Tests

                20.8.3.2.2. By Test Kits

                20.8.3.2.3. By Indication

                20.8.3.2.4. By End User

        20.8.4. Northern Africa Market Analysis

            20.8.4.1. Introduction

            20.8.4.2. Market Analysis and Forecast By Market Taxonomy

                20.8.4.2.1. By Tests

                20.8.4.2.2. By Test Kits

                20.8.4.2.3. By Indication

                20.8.4.2.4. By End User

21. Market Structure Analysis

    21.1. Market Analysis By Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis (%) of Top Players

    21.4. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. ACON Laboratories Inc.

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Sales Footprint

            22.3.1.4. Key Financials

            22.3.1.5. SWOT Analysis

            22.3.1.6. Strategic Overview

                22.3.1.6.1. Marketing Strategy

                22.3.1.6.2. Product Strategy

                22.3.1.6.3. Channel Strategy

        22.3.2. Cardinal Health Inc.

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Sales Footprint

            22.3.2.4. Key Financials

            22.3.2.5. SWOT Analysis

            22.3.2.6. Strategic Overview

                22.3.2.6.1. Marketing Strategy

                22.3.2.6.2. Product Strategy

                22.3.2.6.3. Channel Strategy

        22.3.3. Danaher Corporation

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Sales Footprint

            22.3.3.4. Key Financials

            22.3.3.5. SWOT Analysis

            22.3.3.6. Strategic Overview

                22.3.3.6.1. Marketing Strategy

                22.3.3.6.2. Product Strategy

                22.3.3.6.3. Channel Strategy

        22.3.4. SYSMEX CORPORATION

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Sales Footprint

            22.3.4.4. Key Financials

            22.3.4.5. SWOT Analysis

            22.3.4.6. Strategic Overview

                22.3.4.6.1. Marketing Strategy

                22.3.4.6.2. Product Strategy

                22.3.4.6.3. Channel Strategy

        22.3.5. Abbott Laboratories

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Sales Footprint

            22.3.5.4. Key Financials

            22.3.5.5. SWOT Analysis

            22.3.5.6. Strategic Overview

                22.3.5.6.1. Marketing Strategy

                22.3.5.6.2. Product Strategy

                22.3.5.6.3. Channel Strategy

        22.3.6. Bio-Rad Laboratories

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Sales Footprint

            22.3.6.4. Key Financials

            22.3.6.5. SWOT Analysis

            22.3.6.6. Strategic Overview

                22.3.6.6.1. Marketing Strategy

                22.3.6.6.2. Product Strategy

                22.3.6.6.3. Channel Strategy

        22.3.7. Roche AG

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Sales Footprint

            22.3.7.4. Key Financials

            22.3.7.5. SWOT Analysis

            22.3.7.6. Strategic Overview

                22.3.7.6.1. Marketing Strategy

                22.3.7.6.2. Product Strategy

                22.3.7.6.3. Channel Strategy

        22.3.8. LabCorp (Laboratory Corporation of America Holdings).

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Sales Footprint

            22.3.8.4. Key Financials

            22.3.8.5. SWOT Analysis

            22.3.8.6. Strategic Overview

                22.3.8.6.1. Marketing Strategy

                22.3.8.6.2. Product Strategy

                22.3.8.6.3. Channel Strategy

        22.3.9. Stryker Corporation

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Sales Footprint

            22.3.9.4. Key Financials

            22.3.9.5. SWOT Analysis

            22.3.9.6. Strategic Overview

                22.3.9.6.1. Marketing Strategy

                22.3.9.6.2. Product Strategy

                22.3.9.6.3. Channel Strategy

        22.3.10. Thermo Fisher Scientific, Inc.

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Sales Footprint

            22.3.10.4. Key Financials

            22.3.10.5. SWOT Analysis

            22.3.10.6. Strategic Overview

                22.3.10.6.1. Marketing Strategy

                22.3.10.6.2. Product Strategy

                22.3.10.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 2A: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 2B: Global Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 03: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 04: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 05: Global Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Region

Table 06: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 07: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 08: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 09: North America Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 10: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 11: North America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 13: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 15: Latin America Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 18: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 21: Europe Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 22: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 24: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 26: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 27: South Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 28: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 30: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 31: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 32: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 33: East Asia Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 34: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 36: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 37: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 38: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 39: Oceania Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 40: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

Table 42: Middle East and Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country

Table 43: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Test

Table 44: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, By Test Kits

Table 45: Middle East and Africa Market Volume (Units) Analysis and Forecast 2017 to 2033, By Test Kits

Table 46: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by Indication

Table 47: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2017 to 2033, by End User

List of Charts

Figure 01: Global Market Volume (Units), 2017 to 2022

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,

Figure 03: Urinary Tract Infection Testing, Pricing Analysis per unit (US$), in 2022

Figure 04: Urinary Tract Infection Testing, Pricing Forecast per unit (US$), in 2033

Figure 05: Global Market Value (US$ Million) Analysis, 2017 to 2022

Figure 06: Global Market Forecast & Y-o-Y Growth, 2023 to 2033

Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2033

Figure 08: Global Market Value Share (%) Analysis 2023 and 2033, by Test

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Test

Figure 10: Global Market Attractiveness Analysis 2023 to 2033, by Test

Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, By Test Kits

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022-2033, By Test Kits

Figure 13: Global Market Attractiveness Analysis 2023 to 2033, By Test Kits

Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, by Indication

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Indication

Figure 16: Global Market Attractiveness Analysis 2023 to 2033, by Indication

Figure 17: Global Market Value Share (%) Analysis 2023 and 2033, by End User

Figure 18: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User

Figure 19: Global Market Attractiveness Analysis 2023 to 2033, by End User

Figure 20: Global Market Value Share (%) Analysis 2023 and 2033, by Region

Figure 21: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region

Figure 22: Global Market Attractiveness Analysis 2023 to 2033, by Region

Figure 23: North America Market Value (US$ Million) Analysis, 2017 to 2022

Figure 24: North America Market Value (US$ Million) Forecast, 2023 to 2033

Figure 25: North America Market Value Share, by Test (2023 E)

Figure 26: North America Market Value Share, By Test Kits (2023 E)

Figure 27: North America Market Value Share, by Indication (2023 E)

Figure 28: North America Market Value Share, by End User (2023 E)

Figure 29: North America Market Value Share, by Country (2023 E)

Figure 30: North America Market Attractiveness Analysis by Test, 2023 to 2033

Figure 31: North America Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 32: North America Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 33: North America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 34: North America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 35: USA Market Value Proportion Analysis, 2022

Figure 36: Global Vs. USA Growth Comparison

Figure 37: USA Market Share Analysis (%) by Test, 2022 & 2033

Figure 38: USA Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 39: USA Market Share Analysis (%) by Indication, 2022 & 2033

Figure 40: USA Market Share Analysis (%) by End User, 2022 & 2033

Figure 41: Canada Market Value Proportion Analysis, 2022

Figure 42: Global Vs. Canada. Growth Comparison

Figure 43: Canada Market Share Analysis (%) by Test, 2022 & 2033

Figure 44: Canada Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 45: Canada Market Share Analysis (%) by Indication, 2022 & 2033

Figure 46: Canada Market Share Analysis (%) by End User, 2022 & 2033

Figure 47: Latin America Market Value (US$ Million) Analysis, 2017 to 2022

Figure 48: Latin America Market Value (US$ Million) Forecast, 2023 to 2033

Figure 49: Latin America Market Value Share, by Test (2023 E)

Figure 50: Latin America Market Value Share, By Test Kits (2023 E)

Figure 51: Latin America Market Value Share, by Indication (2023 E)

Figure 52: Latin America Market Value Share, by End User (2023 E)

Figure 53: Latin America Market Value Share, by Country (2023 E)

Figure 54: Latin America Market Attractiveness Analysis by Test, 2023 to 2033

Figure 55: Latin America Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 56: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 57: Latin America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 58: Latin America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 59: Mexico Market Value Proportion Analysis, 2022

Figure 60: Global Vs Mexico Growth Comparison

Figure 61: Mexico Market Share Analysis (%) by Test, 2022 & 2033

Figure 62: Mexico Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 63: Mexico Market Share Analysis (%) by Indication, 2022 & 2033

Figure 64: Mexico Market Share Analysis (%) by End User, 2022 & 2033

Figure 65: Brazil Market Value Proportion Analysis, 2022

Figure 66: Global Vs. Brazil. Growth Comparison

Figure 67: Brazil Market Share Analysis (%) by Test, 2022 & 2033

Figure 68: Brazil Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 69: Brazil Market Share Analysis (%) by Indication, 2022 & 2033

Figure 70: Brazil Market Share Analysis (%) by End User, 2022 & 2033

Figure 71: Argentina Market Value Proportion Analysis, 2022

Figure 72: Global Vs Argentina Growth Comparison

Figure 73: Argentina Market Share Analysis (%) by Test, 2022 & 2033

Figure 74: Argentina Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 75: Argentina Market Share Analysis (%) by Indication, 2022 & 2033

Figure 76: Argentina Market Share Analysis (%) by End User, 2022 & 2033

Figure 77: Europe Market Value (US$ Million) Analysis, 2017 to 2022

Figure 78: Europe Market Value (US$ Million) Forecast, 2023 to 2033

Figure 79: Europe Market Value Share, by Test (2023 E)

Figure 80: Europe Market Value Share, By Test Kits (2023 E)

Figure 81: Europe Market Value Share, by Indication (2023 E)

Figure 82: Europe Market Value Share, by End User (2023 E)

Figure 83: Europe Market Value Share, by Country (2023 E)

Figure 84: Europe Market Attractiveness Analysis by Test, 2023 to 2033

Figure 85: Europe Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 86: Europe Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 87: Europe Market Attractiveness Analysis by End User, 2023 to 2033

Figure 88: Europe Market Attractiveness Analysis by Country, 2023 to 2033

Figure 89: UK Market Value Proportion Analysis, 2022

Figure 90: Global Vs. UK Growth Comparison

Figure 91: UK Market Share Analysis (%) by Test, 2022 & 2033

Figure 92: UK Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 93: UK Market Share Analysis (%) by Indication, 2022 & 2033

Figure 94: UK Market Share Analysis (%) by End User, 2022 & 2033

Figure 95: Germany Market Value Proportion Analysis, 2022

Figure 96: Global Vs. Germany Growth Comparison

Figure 97: Germany Market Share Analysis (%) by Test, 2022 & 2033

Figure 98: Germany Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 99: Germany Market Share Analysis (%) by Indication, 2022 & 2033

Figure 100: Germany Market Share Analysis (%) by End User, 2022 & 2033

Figure 101: Italy Market Value Proportion Analysis, 2022

Figure 102: Global Vs. Italy Growth Comparison

Figure 103: Italy Market Share Analysis (%) by Test, 2022 & 2033

Figure 104: Italy Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 105: Italy Market Share Analysis (%) by Indication, 2022 & 2033

Figure 106: Italy Market Share Analysis (%) by End User, 2022 & 2033

Figure 107: France Market Value Proportion Analysis, 2022

Figure 108: Global Vs France Growth Comparison

Figure 109: France Market Share Analysis (%) by Test, 2022 & 2033

Figure 110: France Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 111: France Market Share Analysis (%) by Indication, 2022 & 2033

Figure 112: France Market Share Analysis (%) by End User, 2022 & 2033

Figure 113: Spain Market Value Proportion Analysis, 2022

Figure 114: Global Vs Spain Growth Comparison

Figure 115: Spain Market Share Analysis (%) by Test, 2022 & 2033

Figure 116: Spain Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 117: Spain Market Share Analysis (%) by Indication, 2022 & 2033

Figure 118: Spain Market Share Analysis (%) by End User, 2022 & 2033

Figure 119: Russia Market Value Proportion Analysis, 2022

Figure 120: Global Vs Russia Growth Comparison

Figure 121: Russia Market Share Analysis (%) by Test, 2022 & 2033

Figure 122: Russia Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 123: Russia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 124: Russia Market Share Analysis (%) by End User, 2022 & 2033

Figure 125: BENELUX Market Value Proportion Analysis, 2022

Figure 126: Global Vs BENELUX Growth Comparison

Figure 127: BENELUX Market Share Analysis (%) by Test, 2022 & 2033

Figure 128: BENELUX Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 129: BENELUX Market Share Analysis (%) by Indication, 2022 & 2033

Figure 130: BENELUX Market Share Analysis (%) by End User, 2022 & 2033

Figure 131: East Asia Market Value (US$ Million) Analysis, 2017 to 2022

Figure 132: East Asia Market Value (US$ Million) Forecast, 2023 to 2033

Figure 133: East Asia Market Value Share, by Test (2023 E)

Figure 134: East Asia Market Value Share, By Test Kits (2023 E)

Figure 135: East Asia Market Value Share, by Indication (2023 E)

Figure 136: East Asia Market Value Share, by End User (2023 E)

Figure 137: East Asia Market Value Share, by Country (2023 E)

Figure 138: East Asia Market Attractiveness Analysis by Test, 2023 to 2033

Figure 139: East Asia Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 140: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 141: East Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 142: East Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 143: China Market Value Proportion Analysis, 2022

Figure 144: Global Vs. China Growth Comparison

Figure 145: China Market Share Analysis (%) by Test, 2022 & 2033

Figure 146: China Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 147: China Market Share Analysis (%) by Indication, 2022 & 2033

Figure 148: China Market Share Analysis (%) by End User, 2022 & 2033

Figure 149: Japan Market Value Proportion Analysis, 2022

Figure 150: Global Vs. Japan Growth Comparison

Figure 151: Japan Market Share Analysis (%) by Test, 2022 & 2033

Figure 152: Japan Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 153: Japan Market Share Analysis (%) by Indication, 2022 & 2033

Figure 154: Japan Market Share Analysis (%) by End User, 2022 & 2033

Figure 155: South Korea Market Value Proportion Analysis, 2022

Figure 156: Global Vs South Korea Growth Comparison

Figure 157: South Korea Market Share Analysis (%) by Test, 2022 & 2033

Figure 158: South Korea Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 159: South Korea Market Share Analysis (%) by Indication, 2022 & 2033

Figure 160: South Korea Market Share Analysis (%) by End User, 2022 & 2033

Figure 161: South Asia Market Value (US$ Million) Analysis, 2017 to 2022

Figure 162: South Asia Market Value (US$ Million) Forecast, 2023 to 2033

Figure 163: South Asia Market Value Share, by Test (2023 E)

Figure 164: South Asia Market Value Share, By Test Kits (2023 E)

Figure 165: South Asia Market Value Share, by Indication (2023 E)

Figure 166: South Asia Market Value Share, by End User (2023 E)

Figure 167: South Asia Market Value Share, by Country (2023 E)

Figure 168: South Asia Market Attractiveness Analysis by Test, 2023 to 2033

Figure 169: South Asia Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 170: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 171: South Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 172: South Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 173: India Market Value Proportion Analysis, 2022

Figure 174: Global Vs. India Growth Comparison

Figure 175: India Market Share Analysis (%) by Test, 2022 & 2033

Figure 176: India Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 177: India Market Share Analysis (%) by Indication, 2022 & 2033

Figure 178: India Market Share Analysis (%) by End User, 2022 & 2033

Figure 179: Indonesia Market Value Proportion Analysis, 2022

Figure 180: Global Vs. Indonesia Growth Comparison

Figure 181: Indonesia Market Share Analysis (%) by Test, 2022 & 2033

Figure 182: Indonesia Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 183: Indonesia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 184: Indonesia Market Share Analysis (%) by End User, 2022 & 2033

Figure 185: Malaysia Market Value Proportion Analysis, 2022

Figure 186: Global Vs. Malaysia Growth Comparison

Figure 187: Malaysia Market Share Analysis (%) by Test, 2022 & 2033

Figure 188: Malaysia Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 189: Malaysia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 190: Malaysia Market Share Analysis (%) by End User, 2022 & 2033

Figure 191: Thailand Market Value Proportion Analysis, 2022

Figure 192: Global Vs. Thailand Growth Comparison

Figure 193: Thailand Market Share Analysis (%) by Test, 2022 & 2033

Figure 194: Thailand Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 195: Thailand Market Share Analysis (%) by Indication, 2022 & 2033

Figure 196: Thailand Market Share Analysis (%) by End User, 2022 & 2033

Figure 197: Oceania Market Value (US$ Million) Analysis, 2017 to 2022

Figure 198: Oceania Market Value (US$ Million) Forecast, 2023 to 2033

Figure 199: Oceania Market Value Share, by Test (2023 E)

Figure 200: Oceania Market Value Share, By Test Kits (2023 E)

Figure 201: Oceania Market Value Share, by Indication (2023 E)

Figure 202: Oceania Market Value Share, by End User (2023 E)

Figure 203: Oceania Market Value Share, by Country (2023 E)

Figure 204: Oceania Market Attractiveness Analysis by Test, 2023 to 2033

Figure 205: Oceania Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 206: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 207: Oceania Market Attractiveness Analysis by End User, 2023 to 2033

Figure 208: Oceania Market Attractiveness Analysis by Country, 2023 to 2033

Figure 209: Australia Market Value Proportion Analysis, 2022

Figure 210: Global Vs. Australia Growth Comparison

Figure 211: Australia Market Share Analysis (%) by Test, 2022 & 2033

Figure 212: Australia Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 213: Australia Market Share Analysis (%) by Indication, 2022 & 2033

Figure 214: Australia Market Share Analysis (%) by End User, 2022 & 2033

Figure 215: New Zealand Market Value Proportion Analysis, 2022

Figure 216: Global Vs New Zealand Growth Comparison

Figure 217: New Zealand Market Share Analysis (%) by Test, 2022 & 2033

Figure 218: New Zealand Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 219: New Zealand Market Share Analysis (%) by Indication, 2022 & 2033

Figure 220: New Zealand Market Share Analysis (%) by End User, 2022 & 2033

Figure 221: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022

Figure 222: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033

Figure 223: Middle East & Africa Market Value Share, by Test (2023 E)

Figure 224: Middle East & Africa Market Value Share, By Test Kits (2023 E)

Figure 225: Middle East & Africa Market Value Share, by Indication (2023 E)

Figure 226: Middle East & Africa Market Value Share, by End User (2023 E)

Figure 227: Middle East & Africa Market Value Share, by Country (2023 E)

Figure 228: Middle East & Africa Market Attractiveness Analysis by Test, 2023 to 2033

Figure 229: Middle East & Africa Market Attractiveness Analysis By Test Kits, 2023 to 2033

Figure 230: Middle East & Africa Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 231: Middle East & Africa Market Attractiveness Analysis by End User, 2023 to 2033

Figure 232: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033

Figure 233: GCC Countries Market Value Proportion Analysis, 2022

Figure 234: Global Vs GCC Countries Growth Comparison

Figure 235: GCC Countries Market Share Analysis (%) by Test, 2022 & 2033

Figure 236: GCC Countries Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 237: GCC Countries Market Share Analysis (%) by Indication, 2022 & 2033

Figure 238: GCC Countries Market Share Analysis (%) by End User, 2022 & 2033

Figure 239: Türkiye Market Value Proportion Analysis, 2022

Figure 240: Global Vs. Türkiye Growth Comparison

Figure 241: Türkiye Market Share Analysis (%) by Test, 2022 & 2033

Figure 242: Türkiye Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 243: Türkiye Market Share Analysis (%) by Indication, 2022 & 2033

Figure 244: Türkiye Market Share Analysis (%) by End User, 2022 & 2033

Figure 245: South Africa Market Value Proportion Analysis, 2022

Figure 246: Global Vs. South Africa Growth Comparison

Figure 247: South Africa Market Share Analysis (%) by Test, 2022 & 2033

Figure 248: South Africa Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 249: South Africa Market Share Analysis (%) by Indication, 2022 & 2033

Figure 250: South Africa Market Share Analysis (%) by End User, 2022 & 2033

Figure 251: Northern Africa Market Value Proportion Analysis, 2022

Figure 252: Global Vs Northern Africa Growth Comparison

Figure 253: Northern Africa Market Share Analysis (%) by Test, 2022 & 2033

Figure 254: Northern Africa Market Share Analysis (%) By Test Kits, 2022 & 2033

Figure 255: Northern Africa Market Share Analysis (%) by Indication, 2022 & 2033

Figure 256: Northern Africa Market Share Analysis (%) by End User, 2022 & 2033

Explore Healthcare Insights

View Reports

Urinary Tract Infection Testing Market